ClinConnect ClinConnect Logo
Search / Trial NCT05507853

Exploring Central Sensitization in Pregnant Women

Launched by GÖTEBORG UNIVERSITY · Aug 17, 2022

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a condition called Pelvic Girdle Pain (PGP), which affects many pregnant women. About half of all pregnant women experience this type of pain, and for some, it can last even years after giving birth. The researchers want to understand how the nervous system might be involved in making this pain worse, which could help identify women at risk of developing long-term pain after pregnancy.

To participate in the study, women must be pregnant with a single baby and between 20 to 30 weeks along in their pregnancy. They should be at least 18 years old and able to read and understand Swedish or English. Women with certain medical conditions or complications will not be eligible. Participants will undergo tests to measure how their nervous system responds to pain and will help researchers learn more about how PGP affects physical activity and overall health. This knowledge could lead to better support for women experiencing chronic pain after pregnancy.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • pregnant (first time pregnant or previous experience of pregnancy)
  • 18 years of age or older
  • have a single foetus pregnancy
  • be in gestational weeks 20-30
  • able to read and understand Swedish or English
  • Exclusion Criteria:
  • no history of a fracture or malignant disease in the back, pelvis, pelvic floor or hips
  • no systemic disease of the musculoskeletal or the nervous system
  • no diseases such as gestational diabetes or diabetes type 1 and 2, hypertension
  • no obstetric complications
  • no contradiction for tests.

About Göteborg University

Göteborg University, a leading academic institution in Sweden, is committed to advancing healthcare through innovative research and clinical trials. With a strong focus on interdisciplinary collaboration, the university leverages its extensive expertise in various fields, including medicine, pharmacology, and social sciences, to address pressing health challenges. By sponsoring clinical trials, Göteborg University aims to contribute to the development of new therapies and improve patient outcomes, while adhering to the highest ethical standards and regulatory requirements. Their dedication to rigorous scientific inquiry and community engagement positions them as a pivotal player in the global health research landscape.

Locations

Göteborg, , Sweden

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials